Donna R. Cryer is founder, president, and CEO of the Global Liver Institute. Cryer has channeled her personal experience as a patient with inflammatory bowel disease and liver transplant recipient into advocacy across a career in law, policy, consulting, public relations, clinical trial recruitment, and non-profit management. Previously, she founded and led CryerHealth, a health care consulting firm providing strategic counsel to biopharmaceutical companies, patient advocacy organizations, and technology firms on patient engagement in health information technology, drug discovery, and clinical decision making. Cryer was named one of the Top Blacks in Healthcare by George Washington University’s Milken Institute School of Public Health and BlackDoctors.org, one of the Top 10 Patients Who Make an Impact by Health 2.0, and one of PharmaVoice’s 100 Most Inspiring People.
Previously
The COVID-19 pandemic forced the world to grapple with a long-standing truth: that poor diversity in early and late stage medical research remains a major threat to health equ...